Liquid chromatography-mass spectrometry system for metabolite-based precision medicine
Lead Research Organisation:
University of Liverpool
Department Name: Biochemistry & Systems Biology
Abstract
Metabolites are small biochemicals present in every human cell, tissue and biofluid. These metabolites are essential for life, are primarily involved in metabolism and include sugars and fats which are important for the generation of energy through metabolism of food. Metabolites have other important roles which help us live including the construction of other biochemicals (proteins and DNA), construction of cell walls with fats and the control of chemical processes in the body in response to environmental changes including eating and exercise. The amounts of metabolites in our bodies change in response to environmental changes or in relation to the development and progression of diseases. As examples, the metabolite lactic acid quickly increases in amounts in muscle tissue and blood during exercise and the metabolite glucose increases in blood in the disease diabetes.
In scientific research we study metabolites to understand how we age and how disease processes start and progress. This research can help us understand how diseases develop, help us identify new treatments for diseases and help us diagnose a disease or define the risk of developing a disease early which reduces the level and intensity of treatment and increases the probability of long term survival. The research to be performed will apply the study of thousands of metabolites and this scientific technique is called metabolomics. We will apply a scientific instrument called liquid chromatography-mass spectrometry to allow detection of metabolites based on their weight as different metabolites have different weights (masses). Metabolomics allows the study of thousands of metabolites in discovery research, identification of a small number of important metabolites related to the clinical question and translation in to clinical practice. Metabolites are already used for disease diagnosis including glucose for diagnosis of diabetes. Metabolomics will be applied to study a range of diseases including cancers (lung, blood colorectal), cardiovascular diseases, hormone-driven diseases and women's health/pregnancy disorders.
Importantly, not all humans are the same in how diseases develop and response to different treatments. Traditional medicine treated everyone as if they were the same. A new era of precision medicine is upon us and is an innovative approach to tailoring disease prevention and treatment that takes into account differences in people's genes, environments, and lifestyles. The goal of precision medicine is to target the right treatments to the right patients at the right time. The studies performed will help develop new precision medicine tools for early disease diagnosis or for development of different treatments.
In scientific research we study metabolites to understand how we age and how disease processes start and progress. This research can help us understand how diseases develop, help us identify new treatments for diseases and help us diagnose a disease or define the risk of developing a disease early which reduces the level and intensity of treatment and increases the probability of long term survival. The research to be performed will apply the study of thousands of metabolites and this scientific technique is called metabolomics. We will apply a scientific instrument called liquid chromatography-mass spectrometry to allow detection of metabolites based on their weight as different metabolites have different weights (masses). Metabolomics allows the study of thousands of metabolites in discovery research, identification of a small number of important metabolites related to the clinical question and translation in to clinical practice. Metabolites are already used for disease diagnosis including glucose for diagnosis of diabetes. Metabolomics will be applied to study a range of diseases including cancers (lung, blood colorectal), cardiovascular diseases, hormone-driven diseases and women's health/pregnancy disorders.
Importantly, not all humans are the same in how diseases develop and response to different treatments. Traditional medicine treated everyone as if they were the same. A new era of precision medicine is upon us and is an innovative approach to tailoring disease prevention and treatment that takes into account differences in people's genes, environments, and lifestyles. The goal of precision medicine is to target the right treatments to the right patients at the right time. The studies performed will help develop new precision medicine tools for early disease diagnosis or for development of different treatments.
Technical Summary
Metabolites are involved in metabolism, in the synthesis of larger biochemicals and cell membranes and in regulatory and signaling pathways. They are important biochemicals which drive many processes important to maintain human health but when these processes are perturbed can lead to the development and progression of human diseases. The study of metabolites in disease onset and progression allows us to understand the pathophysiological mechanisms driving disease development, to identify drugable targets and to identify biomarker panels which can be used for early diagnosis or risk stratification to allow less severe and earlier treatments to be applied which can lead to higher survival rates and lower healthcare costs. In the proposed research we will apply metabolomics in discovery and validation studies using a ultra high performance liquid chromatography-mass spectrometry platform. With this platform we can detect low thousands of metabolites in thousands of samples each year and will apply the platform to a range of clinical diseases including cancers, hormone-related diseases, cardiovascular diseases, women's health, pregnancy disorders and pancreatic exocrine function. These studies will focus on the development of new precision medicine applications which will tailor disease prevention and treatment based on differences in people's genes, environments, and lifestyles. The goal of precision medicine is to target the right treatments to the right patients at the right time.
Publications
Broeckling CD
(2023)
Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples.
in Analytical chemistry
| Description | CRUK-funded MGUS/Multiple Myeloma metabolism research |
| Organisation | University of Birmingham |
| Department | School of Biosciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Our research team has and will continue to perform untargeted and targeted metabolomics analysis of MGUS/smouldering multiple myeloma/multiple myeloma serum/plasma samples from different collected patient cohorts to develop biomarker panels to indicate risk of progression from MGUS to SMM and MM. |
| Collaborator Contribution | The partner (led by Prof. Chris Bunce) has led the successful funding proposal from CRUK and is leading/managing the research funded. |
| Impact | None currently |
| Start Year | 2024 |
| Description | Equine virus-based diseases - biomarkers and pathophysiology |
| Organisation | University of Liverpool |
| Department | School of Veterinary Science Liverpool |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Our team have analysed the collected CSF samples applying untargeted metabolomics assays to determine metabolic changes between healthy and virus-infected horses. The team is currently statistically analysing the data collected. |
| Collaborator Contribution | The partners are based at the Liverpool Veterinary School and have collected CSF samples from healthy horses and horses with specific viruses. |
| Impact | Metabolomics data has been collected and statistical analysis is ongoing. |
| Start Year | 2024 |
| Description | Metabolomic study of acromegaly in collaboration with the University of Birmingham |
| Organisation | University of Birmingham |
| Department | College of Medical and Dental Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The collaboration has the objective to identify a biomarker panel predictive of active/non-active status of acromegaly. The instrument supplied by this research grant was applied to analyse 180 serum samples from acromegaly patients in active or remission status and we also performed statistical analysis of the data collected. |
| Collaborator Contribution | The collaborator designed the biomedical study and collected the biological samples to be analysed. |
| Impact | This is a multi-disciplinary collaboration between biochemists and clinical acromegaly teams. |
| Start Year | 2023 |
| Description | Metabolomics study to identify a biomarker panel for pancreatic exocrine dysfunction |
| Organisation | University of Birmingham |
| Department | College of Medical and Dental Sciences |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | The research objective was to identify a biomarker panel predictive of pancreatic exocrine insufficiency observed in multiple diseases including pancreatic cancer. The instrument purchased with this grant was applied to analyse 360 serum samples. The research team performed the sample analysis applying untargeted metabolomics assays and statistical analysis of the data. |
| Collaborator Contribution | The partner designed the biomedical study and collected biological samples for metabolomic analysis. |
| Impact | A PhD thesis has been submitted for examination (Sarah Powell-Brett). |
| Start Year | 2022 |
| Description | Research collaboration with Immunocore (UK) |
| Organisation | Immunocore Ltd |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | The instrument funded by this grant has been used in an ongoing collaboration with Immunocore to identify metabolic regulators of immune responses in human cells. Our research team have performed both untargeted and targeted metabolomic analysis of cell extractsm to identify biologically relevant metabolites for further study. |
| Collaborator Contribution | The partner initiated the collaboration and has provided biological samples for analysis. |
| Impact | This is a multi-disciplinary collaboration between biochemists and immunologists. |
| Start Year | 2023 |
| Description | Study of metabolic changes during changes in steroid profiles in humans |
| Organisation | Royal College of Surgeons in Ireland |
| Country | Ireland |
| Sector | Academic/University |
| PI Contribution | Our research team has collected untargeted metabolomics data on human plasma and muscle tissue collected pre and post-intervention and performed statistical analysis of the collected data. |
| Collaborator Contribution | The collaborators performed the clinical study and collected plasma and muscle tissue samples. |
| Impact | None currently |
| Start Year | 2024 |
| Description | Tender-awarded research project with DSTL |
| Organisation | Defence Science & Technology Laboratory (DSTL) |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | The overall project was focused on defining metabolic changes in soldiers at different altitudes in the Himalayas through the collection of dried blood spot samples and their untargeted metabolomic analysis. Our research team performed untargeted metabolomic analysis of 160 dried blood spots, statistical analysis and biological interpretation. An internal report was also written by the team. |
| Collaborator Contribution | The overall project was focused on defining metabolic changes in soldiers at different altitudes in the Himalayas through the collection of dried blood spot samples and their untargeted metabolomic analysis. The partners designed the biological study and colected dried blood spot samples. |
| Impact | An internal report has been shared between the University of Liverpool and DSTL. |
| Start Year | 2023 |
| Description | FEBS Advanced Course on Metabolomics |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | The Liverpool Training Centre for Metabolomics operated a 5-day face-to-face training courses titled 'FEBS Advanced Course: Investigating metabolism in biological systems applying metabolomics - from cells to whole organisms' which includes one day hands-on training on the LC-MS instrument purchased on this grant. The purpose was training of the next generation of metabolism researchers. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.liverpool.ac.uk/health-and-life-sciences/research/liverpool-shared-research-facilities/m... |
| Description | Three-day face-to-face training courses |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | The Liverpool Training Centre for Metabolomics operated three 3-day face-to-face training courses titled 'Introduction to Applying LC-MS in Untargeted Metabolomics' which includes one day hands-on training on the LC-MS instrument purchased on this grant. The purpose was training of the next generation of metabolism researchers. |
| Year(s) Of Engagement Activity | 2023,2024 |
| URL | https://www.liverpool.ac.uk/health-and-life-sciences/research/liverpool-shared-research-facilities/m... |
